Share on StockTwits

ZS Pharma (NASDAQ:ZSPH) major shareholder Park Bioventures Lp Devon bought 160,000 shares of the stock on the open market in a transaction dated Monday, June 23rd. The shares were purchased at an average price of $18.00 per share, with a total value of $2,880,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

ZS Pharma (NASDAQ:ZSPH) traded down 1.14% on Wednesday, hitting $28.58. 66,258 shares of the company’s stock traded hands. ZS Pharma has a 1-year low of $26.50 and a 1-year high of $30.665. The stock’s 50-day moving average is $28.51 and its 200-day moving average is $28.51. The company’s market cap is $46.5 million.

ZS Pharma, Inc is a biopharmaceutical company focused on the development and commercialization of selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.